In January 2009, Dr Ruffolo joined scientific advisory board of Trevena. In addition to that role, Dr Ruffolo has now agreed to become a member of the company’s board of directors.
Dr Ruffolo is a retired president of R&D at Wyeth Pharmaceuticals. Dr Ruffolo also spent 17 years at SmithKline Beecham (now GlaxoSmithKline) and six years at Lilly Research Laboratories.
Dr Ruffolo has received his BS degree in pharmacy, and his PhD degree in pharmacology, both from The Ohio State University.
Maxine Gowen, president and CEO of Trevena, said: “We are delighted to welcome Dr Ruffolo onto our board, where his deep insight and vast experience will help to drive our company forward.”